Viewing Study NCT01503450


Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2025-12-25 @ 2:35 PM
Study NCT ID: NCT01503450
Status: COMPLETED
Last Update Posted: 2012-01-05
First Post: 2012-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition
Sponsor: Dr. Reddy's Laboratories Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module